Nov 28, 2017

Key senator backs incentives over tariffs in solar trade battle

Sen. Jeff Merkley. Photo: J. Scott Applewhite / AP

Sen. Jeff Merkley says domestic solar manufacturers should be helped by incentives instead of tariffs to compete with cheap imports, putting the Oregon Democrat on the side of most of the solar industry and against an Oregon-based manufacturer seeking tariffs from President Trump.

Why it matters: Merkley personifies the challenge facing clean-energy advocates in the pending solar trade battle: He wants to support renewable energy whenever possible, but one of his constituents is telling him cheap imports is hurting his home-state solar manufacturer. Merkley's comments to Axios, made earlier this month on the sidelines of a climate conference in Bonn, Germany, are the first the senator has made on the trade case.

"I would like to see us to take an approach that would assist the American companies so they could lower their prices and compete with industry at lower prices," Merkley said in the interview. He said subsidies to U.S. companies would be a "real win-win."

Two foreign-owned but U.S.-based solar manufacturers — Georgia-based Suniva and Oregon-based SolarWorld — are asking the Trump administration to impose tariffs on cheap solar imports. Most experts say tariffs would hurt deployment of American solar energy because the U.S. industry depends heavily on cheap panels from China and other Asian countries, but there's less consensus about how big the impact could be, while other experts say a remedy could at least temporarily help domestic panel makers.

For the record: A SolarWorld representative said the company appreciated Merkley's advocacy but added: "We believe that an appropriate remedy by the President to save and rebuild U.S. solar manufacturing must include tariffs and quotas as well as funding or incentives."

What's next: The United States Trade Representative holds a hearing on the trade case Dec. 6, and the White House has a Jan. 12 deadline to make a final decision. A Trump administration official has said the president is likely to issue tariffs on solar imports, given his protectionist bent.

Merkley didn't go into detail about what kind of incentives he could support, but according to the senator's office, he wouldn't rule out a remedy that could impose quotas on the amount of imports allowed or auction of import licenses, the latter which works kind of like a tariff in that it imposes an extra cost on imported solar panels because companies would have to buy import licenses.

Flashback: Merkley supported a similar, though much narrower, trade case a few years ago, where SolarWorld asked for tariffs against Chinese imports only. This latest case is asking for tariffs against all imports of the most popular kind of solar panel, under the argument Chinese companies have outsourced their manufacturing to other Southeast Asian countries to get around earlier trade barriers.

Between the lines: Merkley is taking a more cautious approach this time around, largely because it's a broader trade request. Oregon's senior senator, Democrat Ron Wyden, has been more outspokenly critical of what cheap imports are doing to domestic solar manufacturers.

Go deeper: Check out my recent Harder Line column on this topic: America's Chinese solar dilemma.

Go deeper

Minneapolis unrest as hundreds protest death of George Floyd

Protesters and police clash during demonstration on Wednesday over the death of George Floyd in custody outside the Third Police Precinct. Photo: Kerem Yucel/AFP via Getty Images

Minneapolis police clashed for a second night with protesters demonstrating the death of George Floyd, an African American man who died in police custody.

The latest: Minnesota Gov. Tim Walz tweeted late Wednesday that the situation where the clashes were taking place was "extremely dangerous" as he urged people to leave the area. There were multiple news reports of police firing tear gas at protesters and of some people looting a Target store.

Blue Cross Blue Shield insurers sue CVS, alleging drug pricing fraud

Photo: John Lamparski/SOPA Images/LightRocket via Getty Images

Six Blue Cross Blue Shield insurers have sued CVS Health, alleging the pharmacy chain overcharged them based on "artificially inflated prices" for generic drugs and concealed the true cash prices of those drugs.

The big picture: CVS has faced legal scrutiny over its cash discount programs since 2015, and this lawsuit adds big names to a mounting problem.

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

New Zealand has only eight active novel coronavirus cases and no COVID-19 patients in hospital after another day of zero new infections. However, the death toll rose to 22.

Zoom in: A top health official told a briefing a 96-year-old woman "was regarded to having recovered from COVID-19 at the time of her death, and COVID-19 is not recorded as the primary cause of her death on her death certificate." But it was decided to include her in the overall tally of deaths related to the virus.